BRPI0511864A - uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento - Google Patents

uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento

Info

Publication number
BRPI0511864A
BRPI0511864A BRPI0511864-6A BRPI0511864A BRPI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A
Authority
BR
Brazil
Prior art keywords
preparation
combination
acetate
medicament
ethinyl estradiol
Prior art date
Application number
BRPI0511864-6A
Other languages
English (en)
Inventor
Janine Klose
Johannes Bartholomaus
Klaus-Michael Wilsmann
Georg Schramm
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0511864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of BRPI0511864A publication Critical patent/BRPI0511864A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

USO DE UMA COMBINAçãO DE ETINILESTRADIOL E ACETATO DE CLORMADINONA PARA A PREPARAçãO DE UM MEDICAMENTO. A invenção se refere ao uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento, que é utilizado simultaneamente para o tratamento de alterações causadas por androgênios, para a terapia hormonal substitutiva, para o tratamento da dismenorréia, para a estabilização do ciclo menstrual, para o tratamento de doenças resultantes do ciclo menstrual e para a anticoncepção em mulheres.
BRPI0511864-6A 2004-05-28 2005-05-27 uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento BRPI0511864A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004026669A DE102004026669A1 (de) 2004-05-28 2004-05-28 Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
PCT/EP2005/005764 WO2005115402A1 (de) 2004-05-28 2005-05-27 Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels

Publications (1)

Publication Number Publication Date
BRPI0511864A true BRPI0511864A (pt) 2008-01-22

Family

ID=34982562

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511864-6A BRPI0511864A (pt) 2004-05-28 2005-05-27 uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento

Country Status (11)

Country Link
US (1) US20050267081A1 (pt)
EP (1) EP1753435A1 (pt)
AR (1) AR049195A1 (pt)
AU (1) AU2005247101B2 (pt)
BR (1) BRPI0511864A (pt)
DE (1) DE102004026669A1 (pt)
EC (1) ECSP067030A (pt)
MX (1) MXPA06013800A (pt)
PE (1) PE20060402A1 (pt)
RU (1) RU2394579C2 (pt)
WO (1) WO2005115402A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
DE102006003509A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Kontrazeptivum
DE102006062119A1 (de) * 2006-12-22 2008-06-26 Grünenthal GmbH Arzneimittel zur Behandlung von Hauterkrankungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US6511970B1 (en) * 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6326392B1 (en) * 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
AU3567699A (en) * 1998-04-17 1999-11-08 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
DK1390040T3 (da) * 2001-05-18 2007-04-23 Pantarhei Bioscience Bv Farmaceutisk præparat til anvendelse i hormonerstatningsterapi
CN1674880A (zh) * 2002-08-15 2005-09-28 惠氏公司 用于治疗体温调节机能障碍的5HT2a受体的激动作用
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE

Also Published As

Publication number Publication date
RU2394579C2 (ru) 2010-07-20
US20050267081A1 (en) 2005-12-01
PE20060402A1 (es) 2006-07-12
DE102004026669A1 (de) 2005-12-15
MXPA06013800A (es) 2007-02-02
RU2006145077A (ru) 2008-07-10
WO2005115402A1 (de) 2005-12-08
AU2005247101A1 (en) 2005-12-08
EP1753435A1 (de) 2007-02-21
AU2005247101B2 (en) 2011-02-17
ECSP067030A (es) 2006-12-29
AR049195A1 (es) 2006-07-05

Similar Documents

Publication Publication Date Title
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
MX363536B (es) Gel transdermico de progestina/estradiol.
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
EA201201403A1 (ru) Очень низкодозированные твердые пероральные лекарственные формы для гзт
HUP0204211A2 (hu) Szelektív ösztrogén receptor modulátorok és ösztrogének kombinációi és ezeket tartalmazó gyógyszerkészítmények
HUP0302093A2 (hu) Konjugált ösztrogének és medroxi-progeszteron-acetát alkalmazása hormonpótló terápiában használható gyógyszerkészítmény előállítására
BRPI0614415A2 (pt) método de indução de contracepção, terapia de reposição hormonal, tratamento de doença dependente de hormônio, sincronização de estro, ou tratamento de sintomas relacionados com ciclo em um mamífero, regime de contracepção, uso de um composto, composto, e, produto de contracepção
DK1443966T3 (da) Fremgangsmåde til forebyggelse eller behandling af benigne gynækologiske lidelser
CU20140064A7 (es) Derivados de 6,7- dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos
AR033042A1 (es) Terapia de reemplazo hormonal
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
BRPI0511864A (pt) uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento
DE60104194D1 (de) Kombination der progesteron und mifepristone für krebs-therapie
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
ATE395047T1 (de) Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält
TW200640468A (en) Pharmaceutical product for oral contraception
EA200900829A1 (ru) Фармацевтический препарат для уменьшения эндометриоза
CR20230127A (es) Nueva composición de anticonceptivo oral de liberación modificada
BRPI0511931A (pt) uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos
TW200744609A (en) Process for producing a single-phase pharmaceutical product for oral therapy of dysfunctional uterine bleeding
DK1937274T3 (da) Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception
UA22273U (en) Method for treatment of osteoporosis
TH98166B (th) การจัดการการเกิดการตกเลือดอย่างมากในการจัดควบคุมยาคุมกำเนิดชนิดฮอร์โมนแบบมีการขยายเวลา
DE602006018471D1 (de) 17-alpha-substituierte derivate von östradiol mit wundheilender wirkung

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: RICHTER GEDEON NYRT. (HU)

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]